Physician

Miguel Alberto Melo-Bicchi, MD

According to 2025 Medicare claims, Miguel Melo-Bicchi, MD (NPI: 1487093654) practices epileptologists in the Miami-Miami Beach-Kendall, FL market, with the plurality of this provider's patient population coming from Miami-Dade, FL. This provider's primary affiliated billing organization is NEUROSCIENCE CONSULTANTS LLP (NPI: 1346217452; TIN: 542107535) and primary practice location at 33176-2309. Melo-Bicchi is affiliated with the West Michigan Accountable Care Organization, LLC (ACO ID: A4626), participating under the MSSP model.

Melo-Bicchi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 307 traditional Medicare patients, billed 24,543 HCPCS/CPT codes, and received $827,179 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 599 prescription claims across 125 beneficiaries totaling $499,888 in drug costs, led by Nurtec Odt (Rimegepant Sulfate). Open Payments data shows 147 records totaling $3,550. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $13,116 to $827,179. Similarly, Part D prescription costs have moved sharply higher in recent years, from $3,667 to $499,888. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$414K$827K2020 Medicare payment: $13,116 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $40,346 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $24,560 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $349,835 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $827,179 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
202060115$13,116
2021231296$40,346
2022188236$24,560
20232822,313$349,835
202430724,543$827,179

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$250K$500K2017 Drug cost: $3,667 (USD; Tot_Drug_Cst)2018 Drug cost: $21,078 (USD; Tot_Drug_Cst)2019 Drug cost: $49,410 (USD; Tot_Drug_Cst)2020 Drug cost: $205,358 (USD; Tot_Drug_Cst)2021 Drug cost: $2,113 (USD; Tot_Drug_Cst)2023 Drug cost: $34,960 (USD; Tot_Drug_Cst)2024 Drug cost: $499,888 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R34$3,667
201814138$21,078
201916111$49,410
20202486$205,358
2021N/R11$2,113
2022N/RN/RN/R
202366266$34,960
2024125599$499,888

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes3030$143
99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes128129$109
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more98179$98
95816Measurement of brain wave activity (eeg), awake and drowsy3131$46
G0444Annual depression screening, 5 to 15 minutes3737$19

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Nurtec OdtRimegepant Sulfate14398$14,694
Memantine HclMemantine Hcl401,701$1,277
LevetiracetamLevetiracetam231,695$1,255
GabapentinGabapentin772,958$1,182
CarbamazepineCarbamazepine19980$499

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.147$3,550UCB, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Miguel Alberto Melo-Bicchi, MD?

Tedicare shows public-source Medicare data for Miguel Alberto Melo-Bicchi, MD (NPI 1487093654), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Miguel Alberto Melo-Bicchi, MD have ACO affiliation data?

Miguel Alberto Melo-Bicchi, MD is shown with ACO affiliation data for West Michigan Accountable Care Organization, LLC (MSSP, ACO ID A4626).

What billing organization is linked to Miguel Alberto Melo-Bicchi, MD?

Miguel Alberto Melo-Bicchi, MD is linked to NEUROSCIENCE CONSULTANTS LLP (billing NPI 1346217452) in the available physician profile data.

Does Miguel Alberto Melo-Bicchi, MD have Open Payments data?

Miguel Alberto Melo-Bicchi, MD has 147 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.